{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T14:34:35Z","timestamp":1783953275395,"version":"3.55.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bull Exp Biol Med"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s10517-020-04723-x","type":"journal-article","created":{"date-parts":[[2020,3,7]],"date-time":"2020-03-07T12:02:53Z","timestamp":1583582573000},"page":"423-426","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Plasma Cytokines Profile in Patients with Parkinson\u2019s Disease Associated with Mutations in GBA Gene"],"prefix":"10.1007","volume":"168","author":[{"given":"I. V.","family":"Miliukhina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. S.","family":"Usenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. A.","family":"Senkevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A.","family":"Nikolaev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. A.","family":"Timofeeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. A.","family":"Agapova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. V.","family":"Semenov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. E.","family":"Lubimova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. A.","family":"Totolyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. N.","family":"Pchelina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,7]]},"reference":[{"issue":"1","key":"4723_CR1","first-page":"51","volume":"93","author":"IV Milyukhina","year":"2015","unstructured":"Milyukhina IV, Karpenko MN, Klimenko VM. Clinical parameters and the level of certain cytokines in blood and cerebrospinal fluid of patients with Parkinson\u2019s disease. Klin. Med. 2015;93(1):51-55. Russian.","journal-title":"Klin. Med."},{"issue":"10","key":"4723_CR2","doi-asserted-by":"publisher","first-page":"81","DOI":"10.17116\/jnevro201711710181-86","volume":"117","author":"KA Senkevich","year":"2017","unstructured":"Senkevich KA, Miliukhina IV, Beletskaia MV, Gracheva EV, Kudrevatykh AV, Nikolaev MA, Emelyanov AK, Kopytova AE, Timofeeva AA, Yakimovskii AF, Pchelina SN. The clinical features of Parkinson\u2019s disease in patients with mutations and polymorphic variants of GBA gene. Zh. Nevrol. Psikhiatr. 2017;117(10):81-86. Russian.","journal-title":"Zh. Nevrol. Psikhiatr."},{"issue":"7","key":"4723_CR3","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1001\/jamaneurol.2013.1274","volume":"70","author":"LM Chahine","year":"2013","unstructured":"Chahine LM, Qiang J, Ashbridge E, Minger J, Yearout D, Horn S, Colcher A, Hurtig HI, Lee VM, Van Deerlin VM, Leverenz JB, Siderowf AD, Trojanowski JQ, Zabetian CP, Chen-Plotkin A. Clinical and biochemical differences in patients having Parkinson disease with vs without GBA mutations. JAMA Neurol. 2013;70(7):852-858.","journal-title":"JAMA Neurol."},{"key":"4723_CR4","unstructured":"Emelyanov AK, Usenko TS, Tesson C, Senkevich KA, Nikolaev MA, Miliukhina IV, Kopytova AE, Timofeeva AA, Yakimovsky AF, Lesage S, Brice A, Pchelina SN. Mutation analysis of Parkinson\u2019s disease genes in a Russian data set. Neurobiol. Aging. 2018;71:267.e7-267.e10. doi: 10.1016\/j.neurobiolaging. 2018.06.027"},{"key":"4723_CR5","doi-asserted-by":"crossref","unstructured":"Gardai SJ, Mao W, Sch\u00fcle B, Babcock M, Schoebel S, Lorenzana C, Alexander J, Kim S, Glick H, Hilton K, Fitzgerald JK, Buttini M, Chiou SS, McConlogue L, Anderson JP, Schenk DB, Bard F, Langston JW, Yednock T, Johnston JA. Elevated alpha-synuclein impairs innate immune cell function and provides a potential peripheral biomarker for Parkinson\u2019s disease. PLoS One. 2013;8(8). e71634. doi: 10.1371\/journal.pone.0071634","DOI":"10.1371\/journal.pone.0071634"},{"key":"4723_CR6","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.neures.2017.11.011","volume":"135","author":"EY Ilyechova","year":"2018","unstructured":"Ilyechova EY, Miliukhina IV, Orlov IA, Muruzheva ZM, Puchkova LV, Karpenko MN. A low blood copper concentration is a co-morbidity burden factor in Parkinson\u2019s disease development. Neurosci. Res. 2018;135:54-62. doi: https:\/\/doi.org\/10.1016\/j.neures.2017.11.011","journal-title":"Neurosci. Res."},{"key":"4723_CR7","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.cellimm.2018.02.011","volume":"327","author":"MN Karpenko","year":"2018","unstructured":"Karpenko MN, Vasilishina AA, Gromova EA, Muruzheva ZM, Miliukhina IV, Bernadotte A. Interleukin-1\u03b2, interleukin- 1 receptor antagonist, interleukin-6, interleukin-10, and tumor necrosis factor-\u03b1 levels in CSF and serum in relation to the clinical diversity of Parkinson\u2019s disease. Cell. Immunol. 2018;327:77-82. doi: https:\/\/doi.org\/10.1016\/j.cellimm.2018.02.011","journal-title":"Cell. Immunol."},{"issue":"3","key":"4723_CR8","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.cyto.2012.07.030","volume":"60","author":"D Koziorowski","year":"2012","unstructured":"Koziorowski D, Tomasiuk R, Szlufik S, Friedman A. Inflammatory cytokines and NT-proCNP in Parkinson\u2019s disease patients. Cytokine. 2012;60(3):762-766. doi: https:\/\/doi.org\/10.1016\/j.cyto.2012.07.030","journal-title":"Cytokine."},{"issue":"12","key":"4723_CR9","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G. MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov. Disord. 2015;30(12):1591-1601. doi: https:\/\/doi.org\/10.1002\/mds.26424","journal-title":"Mov. Disord."},{"issue":"37","key":"4723_CR10","doi-asserted-by":"publisher","first-page":"12,368","DOI":"10.1523\/JNEUROSCI.2102-14.2014","volume":"34","author":"AN Sacino","year":"2014","unstructured":"Sacino AN, Brooks M, McKinney AB, Thomas MA, Shaw G, Golde TE, Giasson BI. Brain injection of \u03b1-synuclein induces multiple proteinopathies, gliosis, and a neuronal injury marker. J. Neurosci. 2014;34(37):12,368-12,378. doi: https:\/\/doi.org\/10.1523\/JNEUROSCI.2102-14.2014","journal-title":"J. Neurosci."},{"issue":"11","key":"4723_CR11","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/S1474-4422(12)70190-4","volume":"11","author":"E Sidransky","year":"2012","unstructured":"Sidransky E, Lopez G. The link between the GBA gene and parkinsonism. Lancet Neurol. 2012;11(11):986-998. doi: https:\/\/doi.org\/10.1016\/S1474-4422(12)70190-4","journal-title":"Lancet Neurol."},{"issue":"18","key":"4723_CR12","first-page":"3853","volume":"20","author":"XM Wang","year":"2016","unstructured":"Wang XM, Zhang YG, Li AL, Long ZH, Wang D, Li XX, Xia JH, Luo SY, Shan YH. Relationship between levels of inflammatory cytokines in the peripheral blood and the severity of depression and anxiety in patients with Parkinson\u2019s disease. Eur. Rev. Med. Pharmacol. Sci. 2016;20(18):3853-3856.","journal-title":"Eur. Rev. Med. Pharmacol. Sci."}],"container-title":["Bulletin of Experimental Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10517-020-04723-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10517-020-04723-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10517-020-04723-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T01:07:50Z","timestamp":1615079270000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10517-020-04723-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["4723"],"URL":"https:\/\/doi.org\/10.1007\/s10517-020-04723-x","relation":{},"ISSN":["0007-4888","1573-8221"],"issn-type":[{"value":"0007-4888","type":"print"},{"value":"1573-8221","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"2 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}